Question 69

Errors associated with Topamax may be appropriately reported to ISMP MERP.

Errors related to Topamax can be reported to the ISMP MERP as it is a prescription medication known for its potential for misuse and the complexity of its dosing, which can lead to significant medication errors.

A) Varivax

Varivax is a vaccine for chickenpox and generally does not fall under the category of medications that are reported for errors to ISMP MERP, as vaccine errors are typically managed through different reporting systems focused on immunizations.

B) M-M-R II

M-M-R II is a vaccine that protects against measles, mumps, and rubella. Similar to Varivax, it is not a medication that would typically be reported to ISMP MERP for errors, as vaccine errors are addressed through specific immunization error reporting pathways.

C) Gardasil 9

Gardasil 9 is a vaccine for human papillomavirus (HPV) and, like the other vaccines, any errors associated with its administration would be reported through vaccine-specific channels rather than ISMP MERP, which focuses on medication errors.

D) Topamax

Topamax, which is used for the treatment of epilepsy and migraine prevention, is a prescription medication that can lead to various medication errors due to its complex dosing and potential side effects. Therefore, errors associated with Topamax are appropriately reported to ISMP MERP.

Conclusion

Topamax is the only option that fits the criteria for reporting to ISMP MERP due to its classification as a prescription medication with a higher risk of medication errors. In contrast, the other options are vaccines, which follow different reporting protocols that do not involve ISMP MERP. This distinction underscores the importance of understanding the type of product when considering error reporting mechanisms.